Bayer CropScience Limited (BOM: 506285)
India
· Delayed Price · Currency is INR | Market Cap | 264.80B |
| Revenue (ttm) | 51.15B |
| Net Income (ttm) | 5.80B |
| Shares Out | 44.94M |
| EPS (ttm) | 128.97 |
| PE Ratio | 45.69 |
| Forward PE | 36.72 |
| Dividend | 140.00 (2.38%) |
| Ex-Dividend Date | Nov 28, 2024 |
| Volume | 1,293 |
| Open | 5,914.45 |
| Previous Close | 6,076.95 |
| Day's Range | 5,875.95 - 6,141.15 |
| 52-Week Range | 4,868.70 - 7,189.90 |
| Beta | n/a |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Nov 8, 2024 |
About Bayer CropScience
Bayer CropScience Limited engages in the manufacture, sale, and distribution of insecticides, fungicides, herbicides, and various other agrochemical products and corn seeds in India, Germany, Bangladesh, and internationally. It provides medicines primarily in the therapeutic areas of cardiology, gynecology, diabetes, oncology, and ophthalmology; and computed tomography, X-Ray, and magnetic resonance imaging devices. In addition, the company offers consumer health products that are used as a daily health solution to treat minor illnesses, as wel... [Read more]
Financial Performance
In 2023, Bayer CropScience's revenue was 51.03 billion, a decrease of -0.71% compared to the previous year's 51.40 billion. Earnings were 7.41 billion, a decrease of -2.33%.
Financial StatementsNews
This ₹6,200+ stock drops 1.5% today – what’s behind the decline?
BAYERCROP is a leading agricultural company specializing in crop protection and seeds. The company focuses on providing innovative solutions to enhance agricultural productivity and sustainability, ca...